These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 1570352)
101. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. Ghigo E; Goffi S; Nicolosi M; Arvat E; Valente F; Mazza E; Ghigo MC; Camanni F J Clin Endocrinol Metab; 1990 Dec; 71(6):1481-5. PubMed ID: 2229304 [TBL] [Abstract][Full Text] [Related]
102. Dynamics of GHRH in third-ventricle cerebrospinal fluid of cattle: relationship with serum concentrations of GH and responses to appetite-regulating peptides. Thomas MG; Amstalden M; Hallford DM; Silver GA; Garcia MD; Keisler DH; Williams GL Domest Anim Endocrinol; 2009 Nov; 37(4):196-205. PubMed ID: 19632078 [TBL] [Abstract][Full Text] [Related]
103. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. Sackmann-Sala L; Ding J; Frohman LA; Kopchick JJ Growth Horm IGF Res; 2009 Dec; 19(6):471-7. PubMed ID: 19386527 [TBL] [Abstract][Full Text] [Related]
104. GHRH-mediated GH release is associated with sympathoactivation and baroreflex resetting: a microneurographic study in healthy humans. Meusel M; Herrmann M; Machleidt F; Franzen KF; Krapalis AF; Sayk F Am J Physiol Regul Integr Comp Physiol; 2019 Jul; 317(1):R15-R24. PubMed ID: 31042402 [TBL] [Abstract][Full Text] [Related]
108. Identification of a tripeptidyl aminopeptidase in the anterior pituitary gland: effect on the chemical and biological properties of rat and bovine growth hormones. Doebber TW; Divor AR; Ellis S Endocrinology; 1978 Nov; 103(5):1794-804. PubMed ID: 748018 [TBL] [Abstract][Full Text] [Related]
109. Long-term (5 years), high daily dosage of dietary agmatine--evidence of safety: a case report. Gilad GM; Gilad VH J Med Food; 2014 Nov; 17(11):1256-9. PubMed ID: 25247837 [TBL] [Abstract][Full Text] [Related]
110. Growth hormone releasing hormone signaling promotes Th17 cell differentiation and autoimmune inflammation. Du L; Ho BM; Zhou L; Yip YWY; He JN; Wei Y; Tham CC; Chan SO; Schally AV; Pang CP; Li J; Chu WK Nat Commun; 2023 Jun; 14(1):3298. PubMed ID: 37280225 [TBL] [Abstract][Full Text] [Related]
111. Efficacy of a growth hormone-releasing hormone agonist in a murine model of cardiometabolic heart failure with preserved ejection fraction. Kanashiro-Takeuchi RM; Takeuchi LM; Dulce RA; Kazmierczak K; Balkan W; Cai R; Sha W; Schally AV; Hare JM Am J Physiol Heart Circ Physiol; 2023 Jun; 324(6):H739-H750. PubMed ID: 36897749 [TBL] [Abstract][Full Text] [Related]
112. Growth hormone-releasing hormone agonist attenuates vascular calcification in diabetic db/db mice. Ren HL; Cai R; Xue R; Zhang Y; Xu Q; Zhang X; Cai R; Sha W; Schally AV; Zhou MS Front Cardiovasc Med; 2023; 10():1102525. PubMed ID: 36742073 [TBL] [Abstract][Full Text] [Related]
113. Agonist of growth hormone-releasing hormone improves the disease features of spinal muscular atrophy mice. Boido M; Gesmundo I; Caretto A; Pedrolli F; Schellino R; Leone S; Cai R; Sha W; Ghigo E; Schally AV; Vercelli A; Granata R Proc Natl Acad Sci U S A; 2023 Jan; 120(2):e2216814120. PubMed ID: 36603028 [TBL] [Abstract][Full Text] [Related]
114. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma. Gesmundo I; Pedrolli F; Vitale N; Bertoldo A; Orlando G; Banfi D; Granato G; Kasarla R; Balzola F; Deaglio S; Cai R; Sha W; Papotti M; Ghigo E; Schally AV; Granata R Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232554 [TBL] [Abstract][Full Text] [Related]
115. Actions and Potential Therapeutic Applications of Growth Hormone-Releasing Hormone Agonists. Schally AV; Zhang X; Cai R; Hare JM; Granata R; Bartoli M Endocrinology; 2019 Jul; 160(7):1600-1612. PubMed ID: 31070727 [TBL] [Abstract][Full Text] [Related]
116. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth. Zarandi M; Cai R; Kovacs M; Popovics P; Szalontay L; Cui T; Sha W; Jaszberenyi M; Varga J; Zhang X; Block NL; Rick FG; Halmos G; Schally AV Peptides; 2017 Mar; 89():60-70. PubMed ID: 28130121 [TBL] [Abstract][Full Text] [Related]
117. Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities. Cai R; Schally AV; Cui T; Szalontay L; Halmos G; Sha W; Kovacs M; Jaszberenyi M; He J; Rick FG; Popovics P; Kanashiro-Takeuchi R; Hare JM; Block NL; Zarandi M Peptides; 2014 Feb; 52():104-12. PubMed ID: 24373935 [TBL] [Abstract][Full Text] [Related]
118. New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity. Toth K; Kovacs M; Zarandi M; Halmos G; Groot K; Nagy A; Kele Z; Schally AV J Pept Res; 1998 Feb; 51(2):134-41. PubMed ID: 9516049 [TBL] [Abstract][Full Text] [Related]
119. Evaluation of the biological potency of new agmatine analogs of growth hormone-releasing hormone in the bovine. Roberge S; Johnson HE; Zarandi M; Schally AV; Reeves JJ Proc Soc Exp Biol Med; 1992 May; 200(1):109-14. PubMed ID: 1570352 [TBL] [Abstract][Full Text] [Related]
120. Evaluation of in vivo [corrected] biological activity of new agmatine analogs of growth hormone-releasing hormone (GH-RH). Bokser L; Zarandi M; Schally AV Life Sci; 1990; 46(14):999-1005. PubMed ID: 2109164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]